In human obesity, IRX3 is a target of the FTO risk loci with allele carriers having increased IRX3 expression in early adipogenesis where it is proposed to regulate adipocyte function and browning through the modulation of mitochondrial genes [37]. Here, IRX3 is linked to obesity due to melanocortin 4 receptor deficiency.